| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.26 | 3e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.26 | 2e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.2 | 5e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.22 | 0.0008 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.05 |